Skip to content

The Safety and Efficacy of Kangduo Endoscopic Robot Surgery System in Ureteral Reimplantation

The Safety and Efficacy of Kangduo Endoscopic Robot Surgery System in Ureteral Reimplantation

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056553
Enrollment
Unknown
Registered
2022-02-07
Start date
2022-02-09
Completion date
Unknown
Last updated
2024-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ureteral outlet obstruction, vesicoureteral reflux disease

Interventions

Experimental group:Endoscopic surgical system (KD-SR-01)

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients requiring ureterovesical replantation including Lich-Gregoir ureteral replantation for lower ureteral stenosis or vesicoureteral reflux; 2. Aged 18-75 years; 3. Agree to sign the informed consent form, follow the doctor's orders, and follow the visitors regularly.

Exclusion criteria

Exclusion criteria: 1. Severe uncontrolled disease or acute infection; 2. Patients with cardiovascular and cerebrovascular diseases, blood system diseases and diabetes that cannot be controlled and cannot meet the surgical standards; 3. Patients with uncontrolled immune system diseases and unable to meet the surgical standards; 4. Patients with previous abdominal and pelvic surgery history and severe abdominal and pelvic adhesions; 5. Pregnant or lactating patients.

Design outcomes

Primary

MeasureTime frame
Symptom;Diuretic renal dynamic imaging;Cystography;Urinary tract CT;Urinary dynamic magnetic resonance;Serum creatinine;Urinary B ultrasonography;

Countries

China

Contacts

Public ContactZhou Liqun

Peking University First Hospital

zhoulqmail@sina.com+86 13601239241

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026